Idexx Laboratories IDXX
NASDAQ IDXX
$518.00 +4.86 (+0.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Idexx Laboratories (IDXX) Research & Development (2009 - 2026)

Updated

Idexx Laboratories (IDXX) recorded Research & Development of $65.43 million in Q2 2026, up 5.7% from $61.9 million a year earlier but down 0.5% from the prior quarter.

Analysis

Idexx Laboratories (IDXX) Research & Development (2009 - 2026) Analysis & Trends

On a TTM basis, Idexx Laboratories' Research & Development came in at $261.47 million as of Jun 30, 2026, up 12.4% year-over-year; for FY2025, it came in at $251.21 million, up 14.3% from FY2024.

  • Annual Research & Development has a five-year compound annual growth rate of 12.2% (FY2020 to FY2025).
  • Across earlier years, Research & Development came in at $219.79 million in FY2024 (+15.1%), $190.95 million in FY2023 (-25.1%), $254.82 million in FY2022 (+58.3%) and $161.01 million in FY2021 (+14.0%).
  • Quarterly Research & Development has ranged from $40.17 million in Q1 2022 to $123.22 million in Q2 2022 over the past five years.
  • On a year-over-year basis, Research & Development has increased for 11 consecutive quarters, with growth averaging 12.3% over the last eight quarters.
  • Peak year-over-year performance for Research & Development in the last five years was growth of 226.9% in Q2 2022, against a decline of 62.3% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $65.79 million (Q1 2026), $66.83 million (Q4 2025) and $63.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 3.65 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 2.34 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn -2.85 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn -4.05 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 1.76 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 2.81 Bn
10 Idexx Laboratories 40.86 Bn 40.07 Bn 779.09 Mn 65.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.43 Mn
Mar 31, 2026 65.79 Mn
Dec 31, 2025 66.83 Mn
Sep 30, 2025 63.42 Mn
Jun 30, 2025 61.90 Mn
Mar 31, 2025 59.06 Mn
Dec 31, 2024 57.73 Mn
Sep 30, 2024 53.98 Mn
Jun 30, 2024 55.45 Mn
Mar 31, 2024 52.64 Mn
Dec 31, 2023 51.81 Mn
Sep 30, 2023 47.97 Mn
Jun 30, 2023 46.51 Mn
Mar 31, 2023 44.67 Mn
Dec 31, 2022 43.42 Mn
Sep 30, 2022 48.01 Mn
Jun 30, 2022 123.22 Mn
Mar 31, 2022 40.17 Mn
Dec 31, 2021 45.31 Mn
Sep 30, 2021 40.43 Mn
API Access

Idexx Laboratories Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=IDXX&period=max&api_key=YOUR_API_KEY